Bal Seal Engineering
Inc. has confirmed it has set a date of Oct. 13, 2010 for the official
rollout of its SYGNUS™ Implantable Contact System, which combines electrical
contacts and isolation seals in a standardized, platform-ready "stack" configuration
to provide a turnkey connecting solution for implantable devices used in
cardiac rhythm management, neuromodulation and neuro sensing therapies.
According to Bal Seal, the new SYGNUS system pairs the
company's Bal Conn™ electrical contact technology with pre-tested silicone
seals, resulting in an "all-inclusive package" engineered to help large and
small device OEMs improve speed to market and eliminate the need for
procurement and testing of individual components.
Bal Seal said the number of contacts and seals in the SYGNUS
system will be configurable to meet unique application and industry
requirements, such as the IS4 standard for cardiac health management devices. The
Canted-coil™ spring contact design will offer multi-point conductivity and low
insertion force, and will compensate for any surface irregularity. The system's
silicone seals will provide dielectric isolation, and the combined stack will
offer resistance to long-term material adhesion and potential fatigue caused by
multiple lead insertion cycles. Contacts in the stack will be force and
resistance tested, and sealing components will be packaged to critical clean
Click here to watch a video of the SYGNUS Implantable Contact System.